Literature DB >> 225416

An interferon-sensitive early step in the establishment of infection of murine cells by murine sarcoma/leukaemia virus.

A G Morris, D C Burke.   

Abstract

NIH 3T3 mouse cells were infected at very high multiplicity with murine sarcoma/leukaemia virus (MSV/MLV) and then cloned. All of the 48 clones obtained were morphologically transformed, all but one showed anchorage-independence of growth, typical of MSV-transformed NIH 3T3 cells and most (91%) produced MSV/MLV. When cells which had been pre-treated with 10(4) units/ml of purified interferon (IF) were infected under the same conditions and then cloned in the presence of the same amount of IF, only 6 of a total of 63 clones were morphologically transformed. All but these 6 showed a degree of anchorage-independence typical of the uninfected parental cells and very few (2.4%) produced virus. Furthermore, the MSV genome could not be rescued in any of the 23 clones tested and only 1 out of 10 clones produced tumours. The properties of these clones remained stable over a period of 10 to 20 passages in the absence of interferon. We conclude that interferon can irreversibly block an early step in the MSV/MLV infectious process.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225416     DOI: 10.1099/0022-1317-43-1-173

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus.

Authors:  M Aboud; Y Hassan
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

2.  Intracellular production of virus particles and viral components in NIH/3T3 cells chronically infected with Moloney murine leukemia virus: effect of interferon.

Authors:  M Aboud; R Kimchi; M Bakhanashvili; S Salzberg
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

3.  Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.

Authors:  D Sergiescu; J Gerfaux; A M Joret; C Chany
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.

Authors:  M S Smith; R J Thresher; J S Pagano
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

5.  Effect of interferon on the penetration of murine leukemia virus and the binding of its genome RNA to polyribosomes at the early stage of infection.

Authors:  S Salzberg; R Shurtz; J Feder; M Aboud
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

6.  Inhibition of retrovirus DNA supercoiling in interferon-treated cells.

Authors:  M Huleihel; M Aboud
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

7.  Effect of interferon on assembly of intracellular Moloney murine leukemia virus particles in chronically infected 3T3/NIH cells.

Authors:  M Aboud; Y Hassan; M Huleihel
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

8.  Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta.

Authors:  V Vieillard; E Lauret; V Rousseau; E De Maeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.